SLC25A32 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.617400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.848600E-01
Normal-vs-Stage2
5.689000E-01
Normal-vs-Stage3
3.681400E-01
Normal-vs-Stage4
6.231200E-01
Stage1-vs-Stage2
7.446800E-01
Stage1-vs-Stage3
4.790000E-01
Stage1-vs-Stage4
3.916600E-01
Stage2-vs-Stage3
5.464800E-01
Stage2-vs-Stage4
1.725390E-01
Stage3-vs-Stage4
1.383380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.636400E-01
Normal-vs-AfricanAmerican
7.618600E-01
Normal-vs-Asian
3.163400E-01
Caucasian-vs-AfricanAmerican
9.851000E-01
Caucasian-vs-Asian
3.458600E-01
AfricanAmerican-vs-Asian
5.356600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.991000E-01
Normal-vs-Female
7.782800E-01
Male-vs-Female
2.683800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.097600E-01
Normal-vs-Age(41-60Yrs)
9.000200E-01
Normal-vs-Age(61-80Yrs)
6.010800E-01
Normal-vs-Age(81-100Yrs)
6.608000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.734190E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.659200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.158000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.204810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.837800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.309000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.713400E-01
Normal-vs-Daily Drinker
3.715200E-01
Normal-vs-Weekly Drinker
7.450600E-01
Normal-vs-Occasional Drinker
9.811000E-01
Normal-vs-Social Drinker
7.027000E-01
Non Drinker-vs-Daily Drinker
7.299600E-01
Non Drinker-vs-Weekly Drinker
2.812000E-01
Non Drinker-vs-Occasional Drinker
3.854000E-02
Non Drinker-vs-Social Drinker
3.964600E-01
Daily Drinker-vs-Weekly Drinker
4.573200E-01
Daily Drinker-vs-Occasional Drinker
1.025970E-01
Daily Drinker-vs-Social Drinker
5.925600E-01
Weekly Drinker-vs-Occasional Drinker
5.218600E-01
Weekly Drinker-vs-Social Drinker
8.868200E-01
Occasional Drinker-vs-Social Drinker
4.361000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.818000E-01
Normal-vs-Grade 2
7.469600E-01
Normal-vs-Grade 3
3.778000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.882400E-01
Grade 1-vs-Grade 3
9.744400E-01
Grade 1-vs-Grade 4
4.818000E-01
Grade 2-vs-Grade 3
9.781200E-01
Grade 2-vs-Grade 4
7.469600E-01
Grade 3-vs-Grade 4
3.778000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.975400E-01
Normal-vs-NonDiabetic
5.605000E-01
Diabetic-vs-NonDiabetic
7.010200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.833030E-01
Normal-vs-NoPancreatitis
6.204600E-01
Pancreatitis-vs-NoPancreatitis
1.486640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.117200E-01
Normal-vs-N1
6.011000E-01
N0-vs-N1
5.248400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.721000E-01
Normal-vs-TP53-NonMutant
6.685600E-01
TP53-Mutant-vs-TP53-NonMutant
9.106000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
